Title | Creator | Relation Is Part Of | ||
---|---|---|---|---|
1 | A 15-Year Summary of Abnormal Visual Fields in the Optic Neuritis Treatment Trial (ONTT) | John L. Keltner; Chris Johnson; Kimberly Cello; Robin Gal; Roy Beck | NANOS 2008: Platform Session II | |
2 | The Characterization and Comparison of OHTS Abnormal Visual Field Classifications Using the 24-2 vs. the 30-2 Testing Strategies | John L. Keltner, MD; Chris A. Johnson, PhD; Kimberly E. Cello, BS; Mae O. Gordon, PhD; Michael A. Kass, MD; Shannan E. Bandermann, MA; and the Ocular Hypertension Treatment Study | NANOS 2002: Poster Presentations | |
3 | Classification of Glaucomatous Visual Field Abnormalities in the Ocular Hypertension Treatment Study (OHTS) | John L. Keltner, MD; Chris A. Johnson, MD | NANOS 2003: Poster Presentations | |
4 | Classification of Visual Field Abnormalities 1, 5 and 10 Years after the Optic Neuritis Treatment Trial (ONTT) | John L. Keltner, MD; Chris A. Johnson, PhD; Kimberly E. Cello, BS; Daniel E. Redline, BA | NANOS 2004: Scientific Platform Presentations (Session 2) | |
5 | Clinical Aspects of Angiora | Roy J. Meckler | NANOS 1987: Interventional Neuroradiology Symposium | |
6 | Visual Field Abnormalities Predict Primary Open-Angle Glaucoma in the Ocular Hypertension Treatment Study (OHTS) | John L. Keltner, MD; Chris A. Johnson, PhD; Juanjuan Fan, PhD; Kimberly E. Cello, BS | NANOS 2004: Poster Presentations |